In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD

Danae A. Delivanis, Victor Manuel Montori

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)JC11
JournalAnnals of Internal Medicine
Volume162
Issue number8
StatePublished - Apr 21 2015

ASJC Scopus subject areas

  • Internal Medicine

Cite this